Table 3.
Number of included patients and uptake ratios stratified for WHO grade and histological subtype
First author | Year of publication | Total patients included/LGG/ HGG/LGA/ HGA/LGO/ HGO (n) | Uptake ratio LGG [mean (SD)] | Uptake ratio HGG [mean (SD)] | Uptake ratio LGA [mean (SD)] | Uptake ratio HGA [mean (SD)] | Uptake ratio LGO [mean (SD)] | Uptake ratio HGO [mean (SD)] |
Berntsson | 2013 | 18/14/4/8/3/6/1 | 2.07 (0.82) | 2.43 (0.44) | 2.14 (1.00) | 2.57 (0.42) | 1.98 (0.56) | 2 (NA) |
Boss | 2010 | 5/2/3/2/3/0/0 | 1.00 (0.42) | 1.96 (0.26) | 1.00 (0.42) | 1.96 (0.26) | NA | NA |
Coope | 2007 | 13/4/9/2/8/2/1 | 1.80 (0.10) | 2.56 (0.65) | 1.8 (0.18) | 2.45 (0.59) | 1.81 (0.03) | 3.47 (NA) |
Gumprecht | 2007 | 15/2/13/2/13/0/0 | 1.44 (0.06) | 2.87 (1.18) | 1.44 (0.06) | 2.87 (1.18) | NA | NA |
Kameyama | 1990 | 11/7/4/7/4/0/0 | 1.64 (0.40) | 2.20 (0.56) | 1.64 (0.40) | 2.20 (0.56) | NA | NA |
Miyake | 2012 | 48/10/38/9/37/1/1 | 1.87 (1.05) | 3.80 (1.66) | 1.91 (1.10) | 3.72 (1.62) | 1.52 (NA) | 6.54 (NA) |
Ogawa | 1993 | 37/14/23/14/23/0/0 | 1.60 (0.57) | 2.52 (0.75) | 1.60 (0.57) | 2.52 (0.75) | NA | NA |
Okita | 2014 | 17/12/5/8/4/4/1 | 1.75 (0.34) | 1.88 (0.48) | 1.68 (0.37) | 2.02 (0.42) | 1.88 (0.26) | 1.32 (NA) |
Sadeghi | 2006 | 14/8/6/7/6/1/0 | 3.13 (1.40) | 4.65 (1.11) | 2.97 (1.42) | 4.65 (1.11) | 4.30 (NA) | NA |
Tateishi | 2014 | 13/4/9/2/6/2/3 | 1.68 (0.38) | 3.32 (0.64) | 2.00 (0.00) | 3.53 (0.70) | 1.35 (0.07) | 2.90 (0.17) |
Tietze | 2015 | 9/2/7/2/6/0/1 | 4.02 (1.29) | 5.17 (1.75) | 4.02 (1.29) | 5.24 (1.90) | NA | 4.76 (NA) |
Torii | 2005 | 27/10/17/10/17/0/0 | 1.35 (0.39) | 2.08 (0.49) | 1.35 (0.39) | 2.08 (0.49) | NA | NA |
Yamamoto | 2008 | 14/4/10/4/10/0/0 | 1.76 (1.60) | 3.02 (0.92) | 1.76 (1.60) | 3.02 (0.92) | NA | NA |
Total (all studies) | NA | 241/93/148/77/140/16/8 | 1.88 (0.93) | 3.08 (1.39) | 1.86 (0.96) | 3.06 (1.38) | 1.97 (0.74) | 3.35 (1.64) |
HGA , high-grade astrocytoma; HGG, high-grade glioma; HGO, high-grade oligodendroglioma: LGA, low-grade astrocytoma; LGG, low-grade glioma; LGO, low-grade oligodendroglioma; NA, not available; SD, standard deviation; WHO, World Health Organization.